Influence of automated visual field testing on intraocular pressure.


Journal

BMC ophthalmology
ISSN: 1471-2415
Titre abrégé: BMC Ophthalmol
Pays: England
ID NLM: 100967802

Informations de publication

Date de publication:
09 Sep 2020
Historique:
received: 15 04 2020
accepted: 21 08 2020
entrez: 10 9 2020
pubmed: 11 9 2020
medline: 15 5 2021
Statut: epublish

Résumé

To evaluate the influence of automated visual field (VF) testing on intraocular pressure (IOP) in patients with ocular hypertension (OHT) or glaucoma. We conducted a prospective observational study in the glaucoma department at Quinze-Vingts National Ophthalmology Hospital in Paris. Ninety-five right eyes of 95 patients followed for glaucoma or OHT were included. IOP was measured three times using a Nidek NT-510 non-contact tonometer within a maximum of 5 min before and after VF testing. Sub analyses using logistic regression analysis were performed to evaluate the impact of gender, age, central corneal thickness (CCT), mean deviation (MD) of the VF, VF test duration and filtration surgery on IOP fluctuations. There was no significant change in IOP after VF testing, with IOP's 15.14 ± 4.00 mmHg before and 14.98 ± 3.33 mmHg after the VF (P = 0.4). The average change in IOP was 0.15 ± 1.82 mmHg. Using multivariate analysis, no effect of the VF test on IOP was found (global model fit R VF testing does not influence IOP as measured with a non-contact tonometer.

Sections du résumé

BACKGROUND BACKGROUND
To evaluate the influence of automated visual field (VF) testing on intraocular pressure (IOP) in patients with ocular hypertension (OHT) or glaucoma.
METHODS METHODS
We conducted a prospective observational study in the glaucoma department at Quinze-Vingts National Ophthalmology Hospital in Paris. Ninety-five right eyes of 95 patients followed for glaucoma or OHT were included. IOP was measured three times using a Nidek NT-510 non-contact tonometer within a maximum of 5 min before and after VF testing. Sub analyses using logistic regression analysis were performed to evaluate the impact of gender, age, central corneal thickness (CCT), mean deviation (MD) of the VF, VF test duration and filtration surgery on IOP fluctuations.
RESULTS RESULTS
There was no significant change in IOP after VF testing, with IOP's 15.14 ± 4.00 mmHg before and 14.98 ± 3.33 mmHg after the VF (P = 0.4). The average change in IOP was 0.15 ± 1.82 mmHg. Using multivariate analysis, no effect of the VF test on IOP was found (global model fit R
CONCLUSION CONCLUSIONS
VF testing does not influence IOP as measured with a non-contact tonometer.

Identifiants

pubmed: 32907553
doi: 10.1186/s12886-020-01622-7
pii: 10.1186/s12886-020-01622-7
pmc: PMC7488059
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

363

Références

Ophthalmology. 1996 Jan;103(1):183-5
pubmed: 8628552
J Glaucoma. 2004 Apr;13(2):178-9; author reply 179
pubmed: 15097267
Am J Ophthalmol. 1979 Dec;88(6):1072-7
pubmed: 517612
Invest Ophthalmol. 1962 Aug;1:480-3
pubmed: 13862325
Am J Optom Physiol Opt. 1984 Jan;61(1):28-30
pubmed: 6702998
Klin Monbl Augenheilkd. 1998 May;212(5):270-4
pubmed: 9677551
Invest Ophthalmol Vis Sci. 1993 Mar;34(3):596-605
pubmed: 8383645
J Glaucoma. 2003 Apr;12(2):114-8
pubmed: 12671465
Biomed Res Int. 2013;2013:370592
pubmed: 24222904
J Glaucoma. 2012 Dec;21(9):590-5
pubmed: 21673592
Klin Monbl Augenheilkd. 1977 Apr;170(4):562-9
pubmed: 886797
Arch Ophthalmol. 2002 Jun;120(6):701-13; discussion 829-30
pubmed: 12049574
Am J Ophthalmol. 1991 Feb 15;111(2):235-9
pubmed: 1992746
Invest Ophthalmol Vis Sci. 2010 Feb;51(2):882-9
pubmed: 19684006
Arch Ophthalmol. 1991 Aug;109(8):1096-8
pubmed: 1867551
Eye (Lond). 2007 Dec;21(12):1479-81
pubmed: 17024224
Curr Opin Ophthalmol. 2004 Apr;15(2):102-6
pubmed: 15021220
ISRN Ophthalmol. 2013 Feb 14;2013:956504
pubmed: 24558609
Ophthalmology. 2011 May;118(5):986-1002
pubmed: 21539982
Invest Ophthalmol Vis Sci. 2012 Nov 13;53(12):7631-5
pubmed: 23099489
Br J Ophthalmol. 1973 Mar;57(3):170-8
pubmed: 4707177
Am J Optom Physiol Opt. 1980 Dec;57(12):902-14
pubmed: 7223834

Auteurs

Samuel Bertaud (S)

Quinze-Vingts National Ophthalmology Hospital, INSERM-DGOS CIC 1423, IHU FOReSIGHT, 28 rue de Charenton, 75012, Paris, France. sam_bertaud@hotmail.com.

Elisabeth Skarbek Borowski (E)

Quinze-Vingts National Ophthalmology Hospital, INSERM-DGOS CIC 1423, IHU FOReSIGHT, 28 rue de Charenton, 75012, Paris, France.

Rachid Abbas (R)

Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France; INSERM U1018, CESP, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.

Christophe Baudouin (C)

Quinze-Vingts National Ophthalmology Hospital, INSERM-DGOS CIC 1423, IHU FOReSIGHT, 28 rue de Charenton, 75012, Paris, France.
Department of Ophthalmology, Ambroise Paré Hospital, AP-HP, IHU FOReSIGHT, Université de Versailles Saint-Quentin en Yvelines, Université Paris Saclay, Versailles, France.
Sorbonne Université, INSERM, CNRS, Institut de la Vision, IHU FOReSIGHT, Paris, France.

Antoine Labbé (A)

Quinze-Vingts National Ophthalmology Hospital, INSERM-DGOS CIC 1423, IHU FOReSIGHT, 28 rue de Charenton, 75012, Paris, France.
Department of Ophthalmology, Ambroise Paré Hospital, AP-HP, IHU FOReSIGHT, Université de Versailles Saint-Quentin en Yvelines, Université Paris Saclay, Versailles, France.
Sorbonne Université, INSERM, CNRS, Institut de la Vision, IHU FOReSIGHT, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH